2026-03-08T04:40:42Z https://kochi.repo.nii.ac.jp/oai

oai:kochi.repo.nii.ac.jp:02000399 2026-01-14T07:47:27Z 617:1716445430240:1734677707521

Targeting VEGF with bevacizumab inhibits malignant effusion formation of primary human herpesvirus 8-unrelated effusion large B-cell lymphoma in vivo 小笠原, 文也 open access © 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. bevacizumab effusion lymphoma targeted therapy vascular endothelial growth factor xenograft model application/PDF 令和6年3月22日授与 高知大学甲総医博第155号 小笠原 文也氏学位申請論文 2023 2022-11 eng doctoral thesis http://hdl.handle.net/10126/0002000399 https://kochi.repo.nii.ac.jp/records/2000399 https://doi.org/10.1111/jcmm.17570 1582-4934 Journal of Cellular and Molecular Medicine 26 22 5580 5589 甲総医博第155号 博士（医学） 2024-03-22 16401 高知大学 https://kochi.repo.nii.ac.jp/record/2000399/files/2023db_Fumiya_Ogasawara.pdf application/pdf 13 MB 2025-01-20